Future work aimed at better understanding the immune cell dynamics within medulloblastomas may also consider first enriching for CD45+ cells prior to bulk RNA sequencing or employing single cell sequencing or single cell proteomics technologies to detect immune signatures in medulloblastoma tissue, though these methods are accompanied with the caveat of tissue processing induced artefacts [reviewed in (54)]. Here, PTPRC is linked to medulloblastoma.